Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients With Mild Pneumonia - An Open-label Randomized Controlled Study -

NCT04600999 is registered in ClinicalTrials.gov with University of Pecs as lead sponsor.

NCT NCT04600999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04600999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients With Mild Pneumonia - An Open-label Randomized Controlled Study -
Lead sponsor
University of Pecs
Phase
Phase 3
Overall status
Completed
Start date
October 7, 2020
Completion date
December 28, 2020
Enrollment
14 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection